Rehabilitation Assessment of Motor Function In Cerebral Palsy Using Explainable AI
2026年8月5日 更新者:Riphah International University
Rehabilitation Assessment of Motor Function in Ambulatory Children With Cerebral Palsy Using Explainable Machine Learning
The goal of this observational study is to develop and validate an AI-based prediction model for functional mobility and gait outcomes in children with cerebral palsy using low-cost clinical and gait data collected in rehabilitation settings in Pakistan.
研究概览
详细说明
Children with cerebral palsy (CP) commonly experience limitations in functional independence and mobility, which significantly affect participation and quality of life.
Accurate assessment of these functional abilities is essential for rehabilitation planning, prognosis estimation, and monitoring treatment outcomes.
However, conventional assessment methods largely depend on therapist observation and standardized clinical scales, which may be subjective, time-consuming, and less sensitive to complex interactions among clinical variables.
研究类型
观察性的
注册 (估计的)
200
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Qamar Mehmood, Phd Rehab
- 电话号码:03335151063
- 邮箱:qamar.mehmood@riphah.edu.pk
学习地点
-
-
-
Islamabad、巴基斯坦
- Alfarabi special education center
-
接触:
- Sidra Ghias, PhD*
- 电话号码:03224356227
- 邮箱:sidrahasan1989@gmail.com
-
接触:
-
首席研究员:
- Sidra Ghias, PhD*
-
Islamabad、巴基斯坦
- Army special education Academy
-
Islamabad、巴基斯坦
- National institute of Rehabilitation medicine
-
接触:
- Sidra Ghias, PhD*
- 电话号码:03224356227
- 邮箱:sidrahasan1989@gmail.com
-
接触:
-
首席研究员:
- Sidra Ghias, PhD*
-
Karachi、巴基斯坦
- Karachi institue of neurological diseases and rehabilitation(KIND-R)
-
接触:
-
首席研究员:
- Sidra Ghias, PhD*
-
接触:
- Sidra Ghias, PhD*
- 电话号码:03314140498
- 邮箱:sidrahasan1989@gmail.com
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
- 成人
接受健康志愿者
不
取样方法
非概率样本
研究人群
Children with cerebral palsy classified within Gross Motor Function Classification System (GMFCS) Levels I-III who are ambulatory with or without assistive devices and receiving routine physiotherapy rehabilitation.
Participants from all cerebral palsy subtypes will be included for clinical, functional, and gait assessment related to AI-based evaluation of functional mobility and gait outcomes.
描述
Inclusion Criteria:
- Age 4 to18 years
- Diagnosed any motor type of cerebral palsy (spastic, dyskinetic, ataxic, mixed),)
- GMFCS levels I -III (able to walk with or without an assistive device).
- All participants must be able to ambulate at least 10 meters with or without an assistive device.
- Capable of following simple verbal instructions.
- Parental informed consent and child assent
Exclusion Criteria:
- Recent orthopedic or neurosurgical interventions (<6 months).
- Uncontrolled seizures affecting gait.
- Non-ambulatory (GMFCS IV-V) or cognitive impairments preventing cooperation.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Ambulatory Children with Spastic Cerebral Palsy (GMFCS I-III)
Children diagnosed with spastic cerebral palsy who are ambulatory and classified within Gross Motor Function Classification System (GMFCS) Levels I to III.
Participants will undergo clinical, functional, and gait assessments for AI-based prediction of functional mobility and gait outcomes
|
Participants will continue receiving their standard/routine physiotherapy rehabilitation program as prescribed by their treating therapist.
The study will involve observational collection of clinical, functional, and gait-related data using standardized assessment tools, and AI-based video analysis.
No additional therapeutic intervention will be administered specifically for research purposes.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Edinburgh visual gait scale (EVGS)
大体时间:Baseline to 6 Months
|
Edinburgh visual gait scale (EVGS) EVGS can be a supportive tool that adds quantitative data instead of only qualitative assessment to a video only gait evaluation.
Interobserver agreement is 60-90% and Kappa values are 0.18-0.85
for the 17 items in EVGS.
Reliability is higher for distal segments (foot/ankle/knee 63-90%; trunk/pelvis/hip 60-76%).
Agreement between EVGS and 3DGA is 52-73%.
|
Baseline to 6 Months
|
|
WeeFIM (Functional Independence Measure for Children)
大体时间:Baseline to 6 months
|
WeeFIM (Functional Independence Measure for Children) Reliability: High internal consistency and ICCs (motor and cognitive scales) ~0.91-0.98 in children with cerebral palsy Validity: Construct and external validity supported (scale fits Rasch model expectations and correlates with related developmental measures)
|
Baseline to 6 months
|
|
GMFM-88
大体时间:Baseline to 6 months followup
|
GMFM (Gross Motor Function Measure) Reliability: Excellent.
Internal consistency Cronbach's α ~0.997-1.00;
intra- and inter-rater ICC ~0.994-0.999
(both GMFM-88 & GMFM-66) Validity: Construct and concurrent validity supported by strong correlations with related motor function classifications (e.g., GMFCS, PEDI mobility)
|
Baseline to 6 months followup
|
|
Markerless Gait Analysis
大体时间:Baseline to 6 months
|
Gait videos will be processed using a validated markerless pose estimation framework . Spatiotemporal and kinematic gait parameters will be extracted, including but not limited to:
|
Baseline to 6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Feasibility of markerless video-based gait analysis for routine physiotherapy assessment in low-resource clinical settings
大体时间:Through study completion, 12 month
|
Feasibility will be evaluated using: (1) video acquisition success rate; (2) data processing completion rate; (3) time required for analysis; and (4) clinician usability and interpretability feedback, obtained through structured questionnaires and semi-structured interviews with practicing physiotherapists regarding SHAP-based model outputs.
|
Through study completion, 12 month
|
|
Predictive accuracy of the machine learning model for gait and motor function
大体时间:At model validation ,post data collection ,6 month
|
Model performance will be evaluated using RMSE, MAE, and R² for continuous outcomes.
Explainability will be assessed using SHAP values, with examination of feature importance consistency across cross-validation folds.
based on gait and motor function data collected from participants with ambulatory cerebral palsy.
|
At model validation ,post data collection ,6 month
|
|
Robustness of model predictive performance and change in functional and gait outcomes across heterogeneous therapy exposure contexts
大体时间:Baseline to 6-month follow-up
|
The Phase 2 trained model will be applied to 6-month follow-up data without retraining.
Predictive performance (RMSE, MAE, R²) will be compared across therapy exposure subgroups (regular vs. irregular/no physiotherapy).
Temporal prognosis will additionally be characterized using change from baseline in GMFM-66, WeeFIM, and EVGS, alongside gait symmetry indices derived from video analysis.
|
Baseline to 6-month follow-up
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Sidra Ghias, PhD* Rehab、Riphah International university Isalambad
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年8月30日
初级完成 (估计的)
2027年6月30日
研究完成 (估计的)
2027年12月30日
研究注册日期
首次提交
2026年5月18日
首先提交符合 QC 标准的
2026年6月1日
首次发布 (实际的)
2026年6月5日
研究记录更新
最后更新发布 (实际的)
2026年8月10日
上次提交的符合 QC 标准的更新
2026年8月5日
最后验证
2026年8月1日
更多信息
与本研究相关的术语
其他研究编号
- RCRAHS-ISB/REC/PhD/011111
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.